Project 2: Understanding Adolescent Trajectories, Exposures and Suscep p172-208

$381,854P50FY2013CANIH

Ohio State University, Columbus OH

Investigators

Mary Ellen Wewerscontact Peter G. Shields

Linked publications, trials & patents

Paper 39184174 Paper 38902313 Paper 38227916 Paper 37821974 Paper 37623843 Paper 37374908 Paper 37227265 Paper 36103627 Paper 35667088 Paper 35543861 Paper 35467923 Paper 35162426 Paper 35060798 Paper 34770180 Paper 34600262 Paper 34112599 Paper 34060633 Paper 33982115 Paper 33754940 Paper 33433626 Paper 33316588 Paper 32853669 Paper 32533801 Paper 32359049 Paper 32149583 Paper 32074292 Paper 31961168 Paper 31908190 Paper 31860793 Paper 31852818 Paper 31848205 Paper 31659004 Paper 31619441 Paper 31363490 Paper 31363489 Paper 31363488 Paper 31276024 Paper 31117806 Paper 31054904 Paper 30772827 Paper 30636822 Paper 30608866 Paper 30601033 Paper 30596152 Paper 30485376 Paper 30397167 Paper 30388067 Paper 30377574 Paper 30346585 Paper 30342488 Paper 30288395 Paper 30285145 Paper 30195247 Paper 30145348 Paper 30009217 Paper 29947729 Paper 29862311 Paper 29746974 Paper 29653256 Paper 29627511 Paper 29625358 Paper 29559222 Paper 29478394 Paper 29444268 Paper 29436898 Paper 29398886 Paper 29236552 Paper 29225669 Paper 29152524 Paper 29057296 Paper 28817323 Paper 28789981 Paper 28732318 Paper 28642230 Paper 28605315 Paper 28525914 Paper 28488230 Paper 28483810 Paper 28385093 Paper 28339596 Paper 28339576 Paper 28315761 Paper 28259846 Paper 28220342 Paper 28031378 Paper 27668270 Paper 27628308 Paper 27617273 Paper 27613917 Paper 27446984 Paper 27341184 Paper 27107746 Paper 27090919 Paper 26980864 Paper 26902875 Trial NCT03501472 Trial NCT03500965 Trial NCT03499340 Trial NCT03375840 Trial NCT02596685

Abstract

Most smokers and smokeless tobacco (ST) users begin before the age of 18. In adolescents, the prevalence of ST use has been increasing and the prevalence of dual use for ST use and smoking is high, and even higher in Ohio than many other states. The current marketing environment will likely make this increase. However, almost nothing is known about adolescent initiation of ST and dual use with their trajectories to regular use and dependence; exposures through biomarkers, and; environmental and genetic risk factors. This project ad- dresses 3 FDA research priorities: 1)

View original record on NIH RePORTER →